Milan, Italy

Stefania Zanotta

This inventor holds 7 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 9 EPO patents. Top assignees: Lofarma S.p.a., Consiglio Nazionale Delle Ricerche. Active years: 2004-2020.

USPTO Granted Patents = 7 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Rome, IT (2004 - 2006)
  • Milan, IT (2013 - 2020)

Company Filing History:


Years Active: 2004-2020

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Stefania Zanotta: Innovator in Allergy Research

Introduction

Stefania Zanotta is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of allergy research, holding a total of 7 patents. Her work focuses on developing hypoallergenic variants and methods to reduce allergenicity while preserving immunogenicity.

Latest Patents

One of her latest patents involves the creation of allergoids derived from allergens. This method allows for the modification of allergenic materials to reduce their allergenicity while maintaining their immunogenic properties. The process includes functionalizing primary amine groups of lysine and arginine residues with specific moieties. Another notable patent is for hypoallergenic variants of Mal d 1, the major allergen from Malus domestica, which has potential applications in treating allergic diseases.

Career Highlights

Throughout her career, Stefania has worked with reputable organizations such as Lofarma S.p.a. and the National Research Council of Italy. Her innovative approaches have positioned her as a key figure in allergy research, contributing to advancements in the treatment of allergic conditions.

Collaborations

Stefania has collaborated with esteemed colleagues, including Daniela Roncarolo and Giovanni Mistrello. These partnerships have further enhanced her research and development efforts in the field.

Conclusion

Stefania Zanotta's work exemplifies the intersection of innovation and healthcare, particularly in allergy research. Her contributions continue to pave the way for advancements in the treatment of allergic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…